 |
PDBsum entry 4btf
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Immunity
39:443-453
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.
|
|
J.M.Murphy,
P.E.Czabotar,
J.M.Hildebrand,
I.S.Lucet,
J.G.Zhang,
S.Alvarez-Diaz,
R.Lewis,
N.Lalaoui,
D.Metcalf,
A.I.Webb,
S.N.Young,
L.N.Varghese,
G.M.Tannahill,
E.C.Hatchell,
I.J.Majewski,
T.Okamoto,
R.C.Dobson,
D.J.Hilton,
J.J.Babon,
N.A.Nicola,
A.Strasser,
J.Silke,
W.S.Alexander.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mixed lineage kinase domain-like (MLKL) is a component of the
"necrosome," the multiprotein complex that triggers tumor necrosis
factor (TNF)-induced cell death by necroptosis. To define the specific role and
molecular mechanism of MLKL action, we generated MLKL-deficient mice and solved
the crystal structure of MLKL. Although MLKL-deficient mice were viable and
displayed no hematopoietic anomalies or other obvious pathology, cells derived
from these animals were resistant to TNF-induced necroptosis unless MLKL
expression was restored. Structurally, MLKL comprises a four-helical bundle
tethered to the pseudokinase domain, which contains an unusual pseudoactive
site. Although the pseudokinase domain binds ATP, it is catalytically inactive
and its essential nonenzymatic role in necroptotic signaling is induced by
receptor-interacting serine-threonine kinase 3 (RIPK3)-mediated phosphorylation.
Structure-guided mutation of the MLKL pseudoactive site resulted in
constitutive, RIPK3-independent necroptosis, demonstrating that modification of
MLKL is essential for propagation of the necroptosis pathway downstream of RIPK3.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |